The iMednet eClinical platform offers a cost-effective solution with a full suite of native tools to simplify and shorten study build times, increase efficiency in study execution, and minimize costs through the duration of the study.
In the past two years, we have seen quick and substantial pivots in the way clinical trials are conducted. Every aspect of a trial has been reshaped, repackaged, or completely transformed.
Read More >
Adaptive trial designs emerged as a means to improve clinical trials based on all available information. High failure rates and increasing costs have driven the industry toward adaptive trial designs….
Read More >
Introduction Real-Word Data (RWD) and Real-World Evidence (RWE) are acronyms that have been thrown around the industry for some time. As healthcare, life sciences companies and regulators look at the potential research opportunities that stem…
Read More >
October is Breast Cancer Awareness Month. The National Breast Cancer Foundation estimates one in eight women in the United States will be diagnosed with breast cancer in her lifetime.1 Most of us know a friend or family…
Read More >
For those who attended the SCDM Live Global Conference, the futuristic style of the virtual meeting and the theme (Future Now: v.2.021) did not disappoint. The conference last week broke…
Read More >
Mednet is excited to once again be a sponsor of the Society of Clinical Data Management’s (SCDM) Global Conference, September 26 – 29. The conference is virtual this year, and the theme is “Future Now v2.021”, which is particularly fitting considering the…
Read More >
Prior to the pandemic, there was a growing interest in shifting clinical trials to virtual or decentralized models to boost patient recruitment, improve retention, reduce costs and more. The pandemic only accelerated…
Read More >
Engaging patients in their care, or ‘patient engagement’, has been an important strategy in the broader healthcare industry for years. Whether it is engaging patients after a surgical procedure to reduce the likelihood of complications…
Read More >
In 2016, 85% of trials failed to finish on time, resulting in up to $8 million per day in financial costs. Today, research teams are rethinking their processes and leveraging…
Read More >
In the third part of our blog series exploring the results of our recent survey on the impact of COVID-19 and the shift toward decentralized trials, we are looking at…
Read More >
